Biora Therapeutics (4ZU) Q2 2023 Earnings Report
DE:4ZU Q2 2023 EPS Results
- Actual EPS
- -EUR 13.12
- Consensus EPS
- -EUR 14.28
- Beat/Miss
- Beat by +EUR 1.16
- One Year Ago EPS
- -EUR 6.69
DE:4ZU Q2 2023 Revenue Results
- Actual Revenue
- EUR 1,784.808
- Expected Revenue
- EUR 17.85K
- Beat/Miss
- Missed by -EUR 16.06K
- YoY Revenue Growth
- -98.08%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- After Close
- Conference Call
- Monday, August 14, 2023
Q2 2023 Earnings Call Audio
DE:4ZU Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4ZU Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2025 | 2025 (Q3) | ―- | -5.43 | ― | |
| Aug 18, 2025 | 2025 (Q2) | ―- | 0.16 | ― | |
| May 07, 2025 | 2025 (Q1) | ―- | ― | ― | |
| Mar 26, 2025 | 2024 (Q4) | -3.12- | -5.58 | ― | |
| Nov 14, 2024 | 2024 (Q3) | -3.44-5.43 | -43.64 | 87.57% (+38.21) | |
| Aug 12, 2024 | 2024 (Q2) | -4.021.61 | -13.12 | 112.24% (+14.72) | |
| May 15, 2024 | 2024 (Q1) | -4.02-1.25 | -14.19 | 91.19% (+12.94) | |
| Mar 26, 2024 | 2023 (Q4) | -5.31-5.58 | -14.37 | 61.18% (+8.79) | |
| Nov 13, 2023 | 2023 (Q3) | -8.25-43.64 | -6.69 | -552.00% (-36.95) | |
| Aug 14, 2023 | 2023 (Q2) | -14.28-13.12 | -6.69 | -96.00% (-6.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed